Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
ABO Blood Group System
10%
Allele
24%
Antibiotic Resistance
34%
Antibiotic-Resistant Bacteria
24%
Antiviral Resistance
9%
Bacterium
19%
Blood Group
10%
Blood Plasma
12%
Cladistics
19%
Cohort Effect
24%
COVID-19
49%
COVID-19 Diagnostics
24%
Drug Resistance
49%
Epidemiology
24%
Genetic Variability
24%
Gram-Negative Bacteria
24%
Hepatitis B
29%
Hepatitis B Virus
69%
Hepatitis C
12%
Hepatitis C Virus Genotype 1
24%
Human Immunodeficiency Virus
46%
Human Immunodeficiency Virus 1
74%
Human Leukocyte Antigen
49%
Human Poliovirus 2
24%
Human Respiratory Syncytial Virus
24%
Immune Escape
9%
Immunoglobulin M
12%
Infection
91%
Infectious Agent
17%
Infectious Disease
91%
Lineages
24%
Lower Respiratory Tract
24%
Pneumococcus
19%
Poliomyelitis Virus
24%
Prevalence
100%
Protease
24%
Proteinase
24%
Quantitative Reverse Transcription Polymerase Chain Reaction
24%
Ribonucleic Acid
10%
Salmonella
13%
Seropositivity
13%
Seroprevalence
31%
Severe Acute Respiratory Syndrome Coronavirus 2
98%
Staphylococcus Aureus
24%
Susceptibility
24%
T Cell
15%
Treponema pallidum
12%
Viral Disease
24%
Virus
27%
Virus Strain
9%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Resistance
24%
Antibiotics
8%
Bloodstream Infection
24%
Case-Control Study
24%
Cross-Sectional Study
7%
Drug Resistance
74%
Efavirenz
5%
Epidemic
12%
Flaccid Paralysis
14%
Gram Negative Bacterium
24%
Hepatitis B
24%
Hepatitis B Virus
19%
HIV
79%
Human Immunodeficiency Virus 1
24%
Human metapneumovirus
7%
Human Poliovirus 2
24%
Immunoglobulin M
9%
Immunoglobulin M Antibody
6%
Incubation Time
12%
Lamivudine
5%
Nevirapine
5%
Nonnucleoside Reverse Transcriptase Inhibitor
11%
Nucleic Acid
8%
Nucleoside
5%
Pneumonia
6%
Poliomyelitis Virus
24%
Prevalence
35%
RNA Directed DNA Polymerase Inhibitor
6%
Salmonella
13%
SARS Coronavirus
49%
Seroepidemiology
24%
Vaccination
12%
Virus
27%
Medicine and Dentistry
Diagnosis
24%
Diseases
8%
Epidemic
24%
Flaccid Paralysis
14%
Health Status
6%
Human Poliovirus 2
24%
Infection
17%
Infectious Disease
54%
Low and Middle Income Countries
8%
Malaria
24%
Molecular Diagnostics
12%
One Health
6%
Pandemic
8%
Pathogen
16%
Poliomyelitis Virus
24%
Polymerase Chain Reaction
12%
Public Health
13%
Rapid Diagnostic Test
6%
Systematic Review
52%
Treatment Option
6%
Tropical Disease
10%
Virus Infection
24%